Intelligence Platform

Patents

Browse 1,166 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 9181253

Adenosine receptor agonists, partial agonists, and antagonists

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9180133

Method for treating uterine fibroids

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9173898

Methods of treating giardiasis

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9175070

Neutralizing antibodies to HIV-1 and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9175062

Human soluble receptor for advanced glycation end products (sRAGE), methods of preparing h

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9175057

Immunogenic peptides and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9175038

Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9173931

Process for preparing polysaccharide-protein conjugate vaccines

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9168266

Hybrid diazeniumdiolated compounds, pharmaceutical compositions, and method of treating ca

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9169297

Subgenomic replicons of the flavivirus dengue

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9169296

Expression and assembly of human group C rotavirus-like particles and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9169182

Chrysophaentin analogs that inhibit FtsZ protein

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9168297

Regulation of skin pigmentation by neuregulin-1 (NRG-1)

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9168291

β-mannosylceramide and stimulation of NKT cell anti-tumor immunity

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9163258

Method for the treatment of obesity

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9150644

Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9151762

Identification of DSG-3 as a biomarker for the detection of metastasis in lymph nodes

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9150926

Diagnosis and treatment of adrenocortical tumors using human microRNA-483

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9144604

Vaccine for Shigella

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9140687

Renal cell carcinoma biomarkers

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9139595

Biologically active macrolides, compositions, and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9133480

Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertio

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9133478

Modified vaccinia Ankara (MVA) virus recombinants comprising heterologous coding sequences

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9128080

Modified T cell receptors and related materials and methods

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)